⚡ This is your brand? Claim your page FREE and bring it to life on AI search.
Promontory Therapeutics | Advancing small molecule immunotherapy
What this score means
Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. Promontory Therapeutics | Advancing small molecule immunotherapy just got measured.
5/10 means Promontory Therapeutics | Advancing small molecule immunotherapy is borderline visible. AI bots can crawl your site but your structured-data signals are thin. You are at risk of being skipped when buyers ask AI for a recommendation.
About Promontory Therapeutics | Advancing small molecule immunotherapy
Promontory Therapeutics is developing novel small molecule immunogenic anti-cancer agents. Their lead agent, PT-112, is a highly potent immunogenic cell death (ICD) inducer, currently in Phase 2 clinical development.
Key Topics
Details
Industry: Technology
phosplatin.comAI Visibility Breakdown
2
Structured Data
8
Content Structure
5
Entity Clarity
4
E-E-A-T Signals
6
Technical AEO
4
AI Discoverability
Is this your brand?
Claim free. You'll see:
Your full 6-category score breakdown
Exact fixes: robots.txt, schema, llms.txt
AI bot crawls from ChatGPT, Claude, Perplexity, Gemini
Personal 50% off code at checkout
Tech Shoppers Do More Research Than Anyone. Are You There When They're Looking?
Tech buyers are the most research-intensive shoppers on the internet.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for Promontory Therapeutics | Advancing small molecule immunotherapy.
Source & Attribution
Scored by Engagemii on June 26, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/phosplatin
Cite this score: Engagemii (2026). "AEO Score for Promontory Therapeutics | Advancing small molecule immunotherapy." Retrieved from https://engagemii.com/aeo/brands/phosplatin
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - AI Brand Discovery and AEO Platform